Aprea Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Doylestown, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Aprea Therapeutics, Inc. has filed 437 SEC EDGAR filings since 12 Jul 2019

SEC filing history

Showing 401-425 of 437 matching filings.

Per page
25
Current page
17
S-1MEF File 333-234053

S-1MEF

Filing date
02 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
02 Oct 2019
Reporting date
02 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3

Filing date
02 Oct 2019
Reporting date
02 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Oct 2019
Reporting date
02 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
02 Oct 2019
Reporting date
02 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
02 Oct 2019
Reporting date
02 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
02 Oct 2019
Reporting date
02 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
02 Oct 2019
Reporting date
02 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
02 Oct 2019
Reporting date
02 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
02 Oct 2019
Reporting date
02 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
02 Oct 2019
Reporting date
02 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
02 Oct 2019
Reporting date
02 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
02 Oct 2019
Reporting date
02 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
02 Oct 2019
Reporting date
02 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
02 Oct 2019
Reporting date
02 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
02 Oct 2019
Reporting date
02 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
02 Oct 2019
Reporting date
02 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-39069

CERT filing

Filing date
02 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-233662

S-1/A

Filing date
02 Oct 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
30 Sep 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
30 Sep 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-39069

8-A12B

Filing date
30 Sep 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-233662

S-1/A

Filing date
27 Sep 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
26 Sep 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
26 Sep 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .